1. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol 1998;159:1224-1228. PMID:
9507840.
2. Yoo YN. Prostatitis. Korean J Urol 1994;35:575-585.
3. Wenninger K, Heiman JR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996;155:965-968. PMID:
8583619.
4. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999;54:229-233. PMID:
10443716.
5. Nickel JC. Prostatitis: evolving management strategies. Urol Clin North Am 1999;26:737-751. PMID:
10584615.
6. Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger RE. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology 1996;48:715-721. PMID:
8911515.
7. Shoskes DA, Hakim L, Ghoniem G, Jackson CL. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003;169:1406-1410. PMID:
12629373.
8. Cho IR. The present and future of prostatitis. Korean J Urol 2008;49:475-489.
9. Osborn DE, George NJ, Rao PN, Barnard RJ, Reading C, Marklow C, et al. Prostatodynia: physiological characteristics and rational management with muscle relaxants. Br J Urol 1981;53:621-623. PMID:
7032641.
10. Lacquaniti S, Destito A, Servello C, Candidi MO, Weir JM, Brisinda G, et al. Terazosine and tamsulosin in non bacterial prostatitis: a randomized placebo-controlled study. Arch Ital Urol Androl 1999;71:283-285. PMID:
10673791.
11. de la Rosette JJ, Karthaus HF, van Kerrebroeck PE, de Boo T, Debruyne FM. Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol 1992;22:222-227. PMID:
1361435.
12. Neal DE Jr, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 1994;43:460-465. PMID:
7512296.
13. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 2003;169:592-596. PMID:
12544314.
14. Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004;171:1594-1597. PMID:
15017228.
15. Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003;62:425-429. PMID:
12946740.
16. Zermann D, Ishigooka M, Schubert J, Schmidt RA. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 2000;38:393-399. PMID:
11025376.
17. Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004;93:991-995. PMID:
15142149.
18. Persson BE, Ronquist G, Ekblom M. Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study. J Urol 1996;155:961-964. PMID:
8583618.
19. Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 2005;173:1252-1255. PMID:
15758763.
20. Shim BS. Complementary and alternative therapy for chronic prostatitis/chronic pelvic pain syndrome. Korean J Urogenital Tract Infect Inflamm 2007;2:143-150.
21. Yang SK, Sung WS, Chung H, Kim TW, Kim HS, Lho YS. Biofeedback and functional electrical stimulation therapy for patients with intractable chronic pelvic pain syndrome. Korean J Urol 2003;44:1220-1224.
22. Cho IR. Evaluation and treatment of patients with prostatitis. Korean J Androl 2005;23:1-11.
23. Yavaşçaoğlu I, Oktay B, Simşek U, Ozyurt M. Role of ejaculation in the treatment of chronic non-bacterial prostatitis. Int J Urol 1999;6:130-134. PMID:
10226823.
24. Blacklock NJ. Anatomical factors in prostatitis. Br J Urol 1974;46:47-54. PMID:
4406038.
25. Kim TH, Kim TH, Kim HR, Lee MK, Myung SC, Kim YS. Detection of cryptic microorganisms in patients with chronic prostatitis by multiplex polymerase chain reaction. Korean J Urol 2007;48:304-309.
26. Nickel JC, Downey J, Johnston B, Clark J. Canadian Prostatitis Research Group. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001;165:1539-1544. PMID:
11342913.
27. Youn CW, Son KC, Choi HS, Kwon DD, Park K, Ryu SB. Comparison of the efficacy of antibiotic monotherapy and antibiotic plus alpha-blocker combination therapy for patients with inflammatory chronic prostatitis/chronic pelvic pain syndrome. Korean J Urol 2008;49:72-76.
28. Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003;169:1401-1405. PMID:
12629372.
29. Minnery CH, Getzenberg RH. Benign prostatic hyperplasia cell line viability and modulation of jm-27 by doxazosin and Ibuprofen. J Urol 2005;174:375-379. PMID:
15947693.